Polypharmacy is a growing and major public health issue, particularly in the geriatric
population. This study aimed to examine the association between polypharmacy and the risk …

The increase in life expectancy without a decrease in the years lived without disability leads
to the rise of the population aged over 65 years prone to polypharmacy. The novel …

The aim of palliative care is to maintain as high a quality of life (QoL) as possible despite a
life-threatening illness. Thus, the prescribed medications need to be evaluated and the …

Background Health-related quality of life (HRQoL) is an important outcome measure when
considering medical treatment; however, the impact of polypharmacy on trajectories of …

Purpose We estimate the association between forgetfulness to take medications as
prescribed and polypharmacy and health-related quality of life (HRQoL) among a cohort of …

The use of multiple medications is common in palliative care, putting patients at risk of
adverse events and a high tablet burden. Deprescribing is the process of reviewing and …

Problem Identification: Patients with cancer experience multiple symptoms, but current
practice is driven by guidelines that address single symptoms. Identifying symptom …

Background: Advanced Parkinson's disease (PD) is a multidimensional neurodegenerative
condition with motor and non-motor symptoms contributing to increasing disability and …

Importance Children with severe neurological impairment (SNI) often take multiple
medications to treat problematic symptoms. However, for children who cannot self-report …

Purpose Palliative cancer patients can benefit from deprescribing of potentially
inappropriate medications (PIMs). Tools and guidelines developed for the geriatric …